Beyond the Blues: A Major Depressive Disorder Quality Improvement Program for Primary Care
The purpose of this program is to improve the knowledge, confidence, and performance of family physicians and other primary care physicians in the diagnosis and management of patients with major depressive disorder (MDD).
Primary care physicians
- Diagnose and monitor MDD in patients using standard, effective measurement tools such as the PHQ-2 and PHQ-9
- Describe the physiological, neurobiological, and environmental factors that contribute to MDD and its clinical presentations
- Develop individualized treatment plans for MDD patients with remission as the goal, taking into consideration both pharmacologic and non-pharmacologic options, such as psychotherapy and exercise
- Employ shared decision-making or the use of decision aids when creating a treatment plan for patients with MDD
- Engage the mental health medical neighborhood to support patients with MDD
Charles A. Goldthwaite, Jr., PhD
Dr. Goldthwaite has no financial conflicts of interest relevant to this activity.
ACCME Accreditation Statement
This enduring material activity, CME Report: Beyond the Blues: A Major Depressive Disorder Quality Improvement Program for Primary Care, has been reviewed and is acceptable for up to 2.0 Prescribed credits by the American Academy of Family Physicians. AAFP certification begins 7/1/2018. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only
the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credit(s)
The New Jersey Academy of Family Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The New Jersey Academy of Family Physicians designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 2.00 AMA PRA Category 1™